Doctor Care Anywhere (ASX:DOC) Revenue Climbs 16% as Subscriptions Expand

Sonal Goyal

30 October 2026 11:39 AM AEDT

Doctor Care Anywhere (ASX:DOC) Revenue Climbs 16% as Subscriptions Expand

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Revenue for the three months to 30 September 2026 was £11.3 million, up 16% on the prior year.
Subscription revenue made up 19% of revenue, compared with 8% in the third quarter of 2025.
Consultations totalled 174,440, an increase of 2.6%, with 74% from repeat patients.
Cash at bank was £8.3 million at 30 September 2026.

Doctor Care Anywhere Group PLC (ASX:DOC) released its unaudited trading update for the three months ended 30 September 2026 on 30 October 2026. The UK telehealth provider reported revenue growth of 16% to £11.3 million, with its weight management service contributing for the first full quarter. The update compares the quarter with the three months ended 30 September 2025 and describes the company as one of the UK's leading private providers of telehealth services.

Revenue Mix and Weight Management

Weight management contributed £1.5 million in its first full quarter within the group. Revenue from the rest of the business was £9.8 million, which was level with the same quarter a year earlier. The contrast shows that the overall increase came from the new service rather than from the existing operations.

Subscription revenue, including weight management, reached £2.2 million. Of that amount, DCA Medicspot contributed £1.5 million, against £0.7 million in the third quarter of 2025. Subscriptions now represent 19% of quarterly revenue, up from 8% a year earlier and 11% in the first half of 2026. The company describes this as a broader revenue base, since recurring income is less dependent on individual consultations.

Patient Activity and Partnerships

Consultations rose 2.6% to 174,440 in the quarter. Repeat patients accounted for 74% of those consultations, a measure the company tracks to show ongoing use of its services.

Since July, the company has added three distribution partnerships. One of these, with Ramsay Health Care UK, began on 20 July and offers self-pay online GP appointments to Ramsay patients. The update describes further onward arrangements, which extend the reach of the service beyond the company's own channels.

Cash Position

Cash at bank stood at £8.3 million at 30 September 2026, compared with £7.7 million at 30 June 2026. The company attributed the increase to a £0.5 million payment received in advance, alongside monthly free cash flow.

The company's reliance on advance payments means part of the cash balance reflects timing rather than earnings in the period, a distinction the update makes clear.

The update also shows a change in the composition of revenue, with recurring subscription income now accounting for a larger proportion of the total. The company's description of this shift as a broader revenue base reflects the growing share of income that does not depend on single consultations. The figures remain unaudited and cover one quarter only.

Final Word

Doctor Care Anywhere's third-quarter update shows revenue growth driven by weight management and a larger share of subscription income. Patient consultations rose at a slower pace, while cash increased over the quarter. The figures are unaudited, and the company's future updates will show whether subscription revenue continues to make up a rising share of the total.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.